A detailed history of Argus Investors' Counsel, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 2,995 shares of TMO stock, worth $1.72 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
2,995
Previous 3,033 1.25%
Holding current value
$1.72 Million
Previous $1.88 Million 16.95%
% of portfolio
1.08%
Previous 1.27%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$501.29 - $612.85 $19,049 - $23,288
-38 Reduced 1.25%
2,995 $1.56 Million
Q3 2024

Oct 21, 2024

SELL
$531.86 - $624.21 $16,487 - $19,350
-31 Reduced 1.01%
3,033 $1.88 Million
Q2 2024

Jul 22, 2024

BUY
$541.52 - $599.02 $28,700 - $31,748
53 Added 1.76%
3,064 $1.69 Million
Q2 2024

Jul 19, 2024

BUY
$541.52 - $599.02 $3,790 - $4,193
7 Added 0.23%
3,011 $1.67 Million
Q1 2024

Apr 24, 2024

SELL
$528.82 - $599.43 $1,586 - $1,798
-3 Reduced 0.1%
3,004 $1.75 Million
Q3 2023

Oct 17, 2023

SELL
$498.29 - $574.41 $270,073 - $311,330
-542 Reduced 15.27%
3,007 $1.52 Million
Q2 2023

Jul 20, 2023

BUY
$508.46 - $591.13 $346,769 - $403,150
682 Added 23.79%
3,549 $1.85 Million
Q1 2023

Apr 20, 2023

SELL
$535.0 - $604.82 $7,490 - $8,467
-14 Reduced 0.49%
2,867 $1.65 Million
Q4 2022

Jan 18, 2023

BUY
$484.71 - $571.37 $32,475 - $38,281
67 Added 2.38%
2,881 $0
Q3 2022

Oct 18, 2022

BUY
$507.19 - $604.49 $15,722 - $18,739
31 Added 1.11%
2,814 $1.43 Million
Q2 2022

Jul 22, 2022

SELL
$500.9 - $612.21 $92,666 - $113,258
-185 Reduced 6.23%
2,783 $1.51 Million
Q1 2022

May 04, 2022

BUY
$524.0 - $644.92 $148,816 - $183,157
284 Added 10.58%
2,968 $1.75 Million
Q4 2021

Jan 25, 2022

BUY
$569.0 - $667.24 $132,577 - $155,466
233 Added 9.51%
2,684 $1.79 Million
Q3 2021

Oct 20, 2021

BUY
$509.53 - $609.78 $84,072 - $100,613
165 Added 7.22%
2,451 $1.4 Million
Q2 2021

Jul 30, 2021

SELL
$441.0 - $508.24 $89,964 - $103,680
-204 Reduced 8.19%
2,286 $1.15 Million
Q1 2021

Apr 19, 2021

SELL
$439.85 - $518.83 $78,733 - $92,870
-179 Reduced 6.71%
2,490 $1.14 Million
Q4 2020

Jan 27, 2021

BUY
$435.06 - $527.66 $36,109 - $43,795
83 Added 3.21%
2,669 $1.24 Million
Q3 2020

Oct 30, 2020

BUY
$359.77 - $441.52 $66,557 - $81,681
185 Added 7.71%
2,586 $1.14 Million
Q2 2020

Jul 27, 2020

BUY
$275.2 - $362.34 $168,147 - $221,389
611 Added 34.13%
2,401 $870,000
Q1 2020

Apr 24, 2020

BUY
$255.3 - $340.05 $17,360 - $23,123
68 Added 3.95%
1,790 $508,000
Q4 2019

Jan 17, 2020

BUY
$271.93 - $328.04 $42,421 - $51,174
156 Added 9.96%
1,722 $559,000
Q3 2019

Oct 17, 2019

BUY
$268.46 - $305.43 $13,959 - $15,882
52 Added 3.43%
1,566 $456,000
Q2 2019

Jul 10, 2019

SELL
$257.51 - $295.55 $389,870 - $447,462
-1,514 Reduced 50.0%
1,514 $445,000
Q2 2019

Jul 10, 2019

BUY
$257.51 - $295.55 $482,316 - $553,565
1,873 Added 162.16%
3,028 $889,000
Q1 2019

Apr 16, 2019

SELL
$212.17 - $273.72 $4,455 - $5,748
-21 Reduced 1.79%
1,155 $316,000
Q4 2018

Feb 06, 2019

BUY
$208.47 - $251.98 $245,160 - $296,328
1,176 New
1,176 $263,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $224B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Argus Investors' Counsel, Inc. Portfolio

Follow Argus Investors' Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.